PerspectiveCancer

Neuregulin 1–activated ERBB4 as a “dedicated” receptor for the Hippo-YAP pathway

See allHide authors and affiliations

Science Signaling  09 Dec 2014:
Vol. 7, Issue 355, pp. pe29
DOI: 10.1126/scisignal.aaa2710

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Signaling

Navigate This Article